To treat or not to treat: dysglycaemia in cystic fibrosis
- PMID: 31429490
- DOI: 10.1111/dme.14112
To treat or not to treat: dysglycaemia in cystic fibrosis
Comment on
-
Cystic fibrosis and insulin therapy: a reality check.Diabet Med. 2019 Nov;36(11):1360-1364. doi: 10.1111/dme.13959. Epub 2019 Apr 24. Diabet Med. 2019. PMID: 30964946 No abstract available.
References
-
- Warren RE. Cystic fibrosis and insulin therapy: a reality check. Diabet Med 2019; 36: 1360-1364.
-
- Chamnan P, Shine BS, Haworth CS, Bilton D, Adler AI. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010; 33: 311-316.
-
- Adler AI, Shine B, Haworth C, Leelarathna L, Bilton D. Hyperglycemia and death in cystic fibrosis-related diabetes. Diabetes Care 2011; 34: 1577-1578.
-
- World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia Geneva, Switzerland; 2006.
-
- Waugh N, Royle P, Craigie I, Ho V, Pandit L, Ewings P et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol Assess 2012;16(24):iii-iv, 1-179.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
